This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping our team to understand which sections of the website you find most interesting. We do not share any your subscription information with third parties. It is used solely to send you notifications about site content occasionally.

  • Smaller Small Medium Big Bigger
  • Default Helvetica Segoe Georgia Times

There are many naturally occurring plant cannabinoids, also known as phytocannabinoids (i.e. phyto = plant). The two most well-known of these are CBD and THC, which are derived from hemp or marijuana, both varietal plants of the Cannabis sativa species. In past years, cannabinoids were defined as “terpene phenolic constituents” of Cannabis known to directly interact with cannabinoid receptors in the body, which are part of the endocannabinoid system (eCBs). However, in more recent years the scientific community has recognized there are several plant compounds that are not from Cannabis but are capable of either directly interacting with cannabinoid receptors or sharing chemical similarity with cannabinoids or both. Consequently, the term phytocannabinoids is now inclusive of these other plant compounds as well as those from Cannabis.1

The first part of this article will review the phytocannabinoid properties of resveratrol, a natural antioxidant compound found in grapes, peanuts2 and Japanese Knotweed (Polygonum cuspidatum),3 providing antioxidant protection to the plants— as well as to humans that consume them.4 The second part of the article will compare resveratrol to CBD in terms of human health benefits.

Resveratrol 101
Resveratrol originally made its introduction splash into the dietary supplement marketplace based upon the consideration that intake of it and other polyphenol compounds from red wine may contribute to the “French paradox”—the unexpectedly low rate of death from cardiovascular disease in the Mediterranean population despite the relatively higher intake of saturated fats.5 Then, the excitement increased with the understanding that resveratrol helped activate the SIRT 1 gene, associated with longevity.6 Since that time, interest in resveratrol has continued to expand due to human research demonstrating its effectiveness for reducing inflammation and other health benefits.

Resveratrol and the eCBs
As research continued, it became evident that resveratrol also affects signaling with endocannabinoid receptors. In turn, this exerts modulatory effects in the survival signaling pathways, neural plasticity (i.e. the ability of the brain to change continuously throughout an individual’s life), as well as a variety of neuroinflammatory and neurodegenerative processes. The therapeutic effects of this ubiquitous signaling system in Alzheimer’s disease, epilepsy, multiple sclerosis, mood and movement disorders, spinal cord injury, and stroke have been well-documented,7 and helps to explain why it is that resveratrol has a broad range of activities.

Resveratrol, eCBs, cognition and mood
Recently, resveratrol is implicated in the biology of nerve growth factor (NGF), a critical player in the maintenance of neuronal growth and function. Likewise, resveratrol has also shown antidepressant-like effects in behavioral studies. The interaction between the nerve growth factor (NGF) and eCBs and their contribution to the antidepressant/emotional activity prompted researchers to further evaluate the mechanism of action of resveratrol. Results were that four-week treatment with resveratrol led to significant and sustained enhancement of NGF and eCB contents in dose-dependent and brain region-specific manner. Essentially, resveratrol like the classical antidepressant, amitriptyline, affects brain NGF and eCB signaling under the regulatory drive of CB1 receptors in the eCBs.8

A practical application of resveratrol effects in this regard were demonstrated in a study9 in which 80 post-menopausal women aged 45–85 years received resveratrol (75 mg, twice daily) or placebo for 14 weeks to examine the effect on cognitive performance and other parameters. Results were that, compared to placebo, significant improvements were observed in the performance of cognitive tasks in the domain of verbal memory (p = 0.041) and in overall cognitive performance (p = 0.020). Mood also tended to improve in multiple measures. In another study, 200 mg of resveratrol daily improved memory performance in association with improved glucose metabolism in older adults.10

Resveratrol, eCBs and inflammation
Resveratrol has been shown to have anti-inflammatory effects with as little as 40 mg/day in normal human subjects.11 This included the reduction of inflammatory markers such as TNFalpha, IL-6, and C-reactive protein, with no changes in the placebo group. Similarly, in postmenopausal women with osteoarthritis pain, 75 mg of resveratrol twice daily significantly reduced pain and improved total well-being.12 Other research has also shown similar results, including research13,14 in patients with ulcerative colitis (a chronic inflammatory bowel disease) receiving 500 mg/day of resveratrol, and research15 in receiving 100 mg/day resveratrol.




40 mg, 100 mg, 150 mg, 500 mg

100 mg, 150 mg, 300 mg


150 mg


Arterial Function24,25

100 mg


Exercise-related muscle fatigue*

500 mg


Fat metabolism/weight loss 27

100 mg, 150 mg, 1500 mg


Appetite Control


15 mg



25 mg



15 mg, 25 mg

But what is resveratrol’s mechanism of action for these anti-inflammatory effects? This was examined in a 6-week resveratrol study16 on rats who were fed a high-fat diet (HFD), which in turn resulted in non-alcoholic steatohepatitis (NASH)—a condition of liver inflammation and damage caused by a buildup of fat in the liver. The HFD caused an increase in body weight, liver index, hepatic lipid accumulation, and inflammation, which was inhibited by resveratrol. Resveratrol also attenuated gut microbial dysbiosis (i.e. imbalance of microorganisms in the gut). Moreover, resveratrol led to a reduction in metabolic endotoxemia and colon inflammation. These benefits appear to have been mediated by resveratrol’s effect on the CB1 and CB2 receptors in the gut eCBs. In short, these data indicate that the eCBs, particularly the expressions of CB1 and CB2, appears to play a crucial role in the resveratrol induced anti-NASH effect by maintaining the gut barrier integrity and inhibiting gut inflammation. Other research17 has also suggested that resveratrol induces peripheral blocking of pain through ì-opioid receptor and CB1 receptor activation by endogenous opioid and endocannabinoid releasing.

CBD 101
Much has been written about CBD elsewhere, so I won’t spend much time in a lengthy reiteration. Rather, here is a short overview. As previously mentioned, cannabidiol, or CBD, is a naturally-occurring phytocannabinoid from hemp. Human clinical research on CBD has revealed that it is effective in helping to reduce stress/anxiety and sleep complaints with daily doses of 25 mg.18,19,20 In a more recent study,21 15 mg of hemp-derived CBD for six weeks led to significant decreases in appetite, along with improvements in sleep quality and duration, and enhancements in “quality of life” scores in healthy humans. An emerging area of CBD research is inflammation and pain. However, considerably higher doses of CBD were used in these studies,22,23 ranging between 100–300 mg/day. Other research on CBD also exists, but those studies center around more serious health issues and require medical intervention.

Comparing resveratrol to CBD (See table above) Although they are both phytocannabinoids, resveratrol and CBD’s applications are not precisely the same. This table demonstrating the specific applications of each, including daily doses used in human research:

In reviewing the areas in which resveratrol and CBD offer benefits, it is clear that there are some distinct differences as well as some overlap. Both offer benefits for pain/inflammation. That being said, there are significant differences in cost. The minimum effective dose of CBD shown to have efficacy for this purpose is exponentially higher than that of the highest dose of resveratrol shown to have efficacy. So for purposes of pain/inflammation, resveratrol is the better choice—although it could certainly be combined with lower, more affordable doses of CBD.

Resveratrol is also the clear winner with regard to cognition/mood, while CBD has the advantage for stress/anxiety. In addition, resveratrol also offers benefits for arterial function and exercise-related muscle fatigue that CBD does not have. Conversely, CBD offers benefits for promoting sleep, while resveratrol does not.

Both resveratrol and CBD have different but complementary effects with regard to weight management. CBD appears to help reduce appetite, while resveratrol has a more direct effect on fat metabolism/weight loss. Hence, both phytocannabinoids could be used together to help achieve a greater overall effect.


  1. Gertsch J, Pertwee RG, Di Marzo V. Phytocannabinoids beyond the Cannabis plant—do they exist? Br J Pharmacol. 2010; 160:523–29.
  2. Soleas GJ, Diamandis EP, Goldberg DM. Resveratrol: A molecule whose time has come? And gone? Clin Biochem 1997;30:91–113.
  3. Baur JA, Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence. Nature reviews. Drug discovery 2006; 5(6):493–506.
  4. Bradamante S, Barenghi L, Villa A. Cardiovascular protective effects of resveratrol. Cardiovasc Drug Rev 2004; 22(3):169–88.
  5. Labinskyy N, Csiszar A, Veress G, Stef G, Pacher P, Oroszi G, Wu J, Ungvari Z. Vascular dysfunction in aging: potential effects of resveratrol, an anti-inflammatory phytoestrogen. Current Medicinal Chemistry 2006; 13(9):989–96.
  6. Borra MT, Smith BC, Denu JM.Mechanism of human SIRT1 activation by resveratrol. J Biol Chem. 2005 Apr 29;280(17):17187–95.
  7. Hassanzadeh P, Atyabi F, Dinarvand R. Resveratrol: More than a phytochemical. Biomed Rev 2015; 26: 13–21.
  8. Hassanzadeh P, Arbabi E, Atyabi F, Dinarvand R. The endocannabinoid system and NGF are involved in the mechanism of action of resveratrol: a multi-target nutraceutical with therapeutic potential in neuropsychiatric disorders. Psychopharmacology (Berl). 2016 Mar;233(6):1087–96.
  9. Evans HM, Howe PR, Wong RH. Effects of Resveratrol on Cognitive Performance, Mood and Cerebrovascular Function in Post-Menopausal Women; A 14-Week Randomised Placebo-Controlled Intervention Trial. Nutrients. 2017 Jan 3;9(1). pii: E27.
  10. Witte AV, Kerti L, Margulies DS, Flöel A. Effects of resveratrol on memory performance, hippocampal functional connectivity, and glucose metabolism in healthy older adults. J Neurosci. 2014 Jun 4;34(23):7862–70.
  11. Ghanim H, Sia CL, Abuaysheh S, Korzeniewski K, Patnaik P, Marumganti A, Chaudhuri A, Dandona P. An antiinflammatory and reactive oxygen species suppressive effects of an extract of Polygonum cuspidatum containing resveratrol. J Clin Endocrinol Metab. 2010 Sep;95(9):E1–8.
  12. Wong RHX, Evans HM, Howe PRC. Resveratrol supplementation reduces pain experience by postmenopausal women. Menopause. 2017 Aug;24(8):916–22.
  13. Samsamikor M, Daryani NE, Asl PR, Hekmatdoost A. Resveratrol Supplementation and Oxidative/Anti-Oxidative Status in Patients with Ulcerative Colitis: A Randomized, Double-Blind, Placebo-controlled Pilot Study. Arch Med Res. 2016 May;47(4):304–9.
  14. Samsami-Kor M, Daryani NE, Asl PR, Hekmatdoost A. Anti-Inflammatory Effects of Resveratrol in Patients with Ulcerative Colitis: A Randomized, Double-Blind, Placebo-controlled Pilot Study. Arch Med Res. 2015 May;46(4):280–5.
  15. Macedo RC, Vieira A1, Marin DP2, Otton R3. Effects of chronic resveratrol supplementation in military firefighters undergo a physical fitness test--a placebocontrolled, double blind study. Chem Biol Interact. 2015 Feb 5;227:89–95.
  16. Chen M, Hou P, Zhou M, Ren Q, Wang X, Huang L, Hui S, Yi L, Mi M. Resveratrol attenuates high-fat diet-induced non-alcoholic steatohepatitis by maintaining gut barrier integrity and inhibiting gut inflammation through regulation of the endocannabinoid system. Clin Nutr. 2019 May 30. pii: S0261-5614(19)30231–6.
  17. Oliveira CDC, Castor MGME, Castor CGME, Costa ÁF, Ferreira RCM, Silva JFD, Pelaez JMN, Capettini LDSA, Lemos VS, Duarte IDG, Perez AC, Santos SHS, Romero TRL. Evidence for the involvement of opioid and cannabinoid systems in the peripheral antinociception mediated by resveratrol. Toxicol Appl Pharmacol. 2019 Apr 15;369:30–8.
  18. Shannon S, Lewis N, Lee H, Hughes S. Cannabidiol (CBD) in Anxiety and Sleep: A large case series. Unpublished. n.d. 10 pgs.
  19. Shannon S, Opila-Lehman J. Cannabidiol Oil for Decreasing Addictive Use of Marijuana: A Case Report. Integrative Medicine. 2015;14(6):31-5.
  20. Shannon S, Opila-Lehman J. Effectiveness of Cannabidiol Oil for Pediatric Anxiety and Insomnia as Part of Posttraumatic Stress Disorder: A Case Report. Perm J. 2016 Fall;20(4):108–111.
  21. Lopez HL, Ziegenfuss TN, Cesar KR, et al. Effects of a CBD-containing Supercritical Fluid Extract of Hemp on Markers of Optimal Wellness, Stress Resilience, and Recovery in Healthy Subjects. Poster presentation. 16th Annual Conference of the International Society of Sports Nutrition (ISSN), Las Vegas, June 13–15, 2019.
  22. Jadoon KA, Ratcliffe SH, Barrett DA, Thomas EL, Stott C, Bell JD, O’Sullivan SE, Tan GD. Efficacy and Safety of Cannabidiol and Tetrahydrocannabivarin on Glycemic and Lipid Parameters in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Pilot Study. Diabetes Care. 2016 Oct;39(10):1777–86.
  23. Cuñetti L, Manzo L, Peyraube R, Arnaiz J, Curi L, Orihuela S. Chronic Pain Treatment With Cannabidiol in Kidney Transplant Patients in Uruguay. Transplant Proc. 2018 Mar;50(2):461–4.
  24. Imamura H, Yamaguchi T, Nagayama D, Saiki A, Shirai K, Tatsuno I. Resveratrol Ameliorates Arterial Stiffness Assessed by Cardio-Ankle Vascular Index in Patients With Type 2 Diabetes Mellitus. Int Heart J. 2017 Aug 3;58(4):577–83.
  25. Pollack RM, Barzilai N, Anghel V, Kulkarni AS, Golden A, O’Broin P, Sinclair DA, Bonkowski MS, Coleville AJ, Powell D, Kim S, Moaddel R, Stein D, Zhang K, Hawkins M, Crandall JP. Resveratrol Improves Vascular Function and Mitochondrial Number but Not Glucose Metabolism in Older Adults. J Gerontol A Biol Sci Med Sci. 2017 Nov 9;72(12):1703–9.
  26. Alway SE, McCrory JL, Kearcher K, Vickers A, Frear B, Gilleland DL, Bonner DE, Thomas JM, Donley DA, Lively MW, Mohamed JS.Resveratrol Enhances Exercise-Induced Cellular and Functional Adaptations of Skeletal Muscle in Older Men and Women. J Gerontol A Biol Sci Med Sci. 2017 Nov 9;72(12):1595–606.
  27. Konings E, Timmers S, Boekschoten MV, Goossens GH, Jocken JW, Afman LA, Müller M, Schrauwen P, Mariman EC, Blaak EE. The effects of 30 days resveratrol supplementation on adipose tissue morphology and gene expression patterns in obese men. Int J Obes (Lond). 2014 Mar;38(3):470–3.

Gene Bruno, MS, MHS

Gene Bruno is the Dean of Academics and Professor of Dietary Supplement Science for Huntington College of Health Sciences (a nationally accredited distance learning college offering diplomas and degrees in nutrition and other health science related subjects. Gene has two undergraduate Diplomas in Nutrition, a Bachelor’s in Nutrition, a Master’s in Nutrition, a Graduate Diploma in Herbal Medicine, and a Master’s in Herbal Medicine. As a 32 year veteran of the Dietary Supplement industry, Gene has educated and trained natural product retailers and health care professionals, has researched and formulated natural products for dozens of dietary supplement companies, and has written articles on nutrition, herbal medicine, nutraceuticals and integrative health issues for trade, consumer magazines, and peer-reviewed publications. Gene's latest book, A Guide to Complimentary Treatments for Diabetes, is available on, and other fine retailers.